Where can I find news about SVNS.L?

The latest headlines, third-party analysis, and SEC filings for Solvonis Therapeutics plc (SVNS.L) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.

Where are SVNS.L's SEC filings?

Solvonis Therapeutics plc (SVNS.L)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

Where are SVNS.L's earnings call transcripts?

Full earnings call transcripts for Solvonis Therapeutics plc (SVNS.L) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

SVNS.L

Solvonis Therapeutics plc

LSE·Biotechnology · Healthcare

GBX 0.13GBX 0.01+6.56%

Market capGBX 884.83M·Aug 26 12:18 PM UTC

News & Analysis

Bank of Montreal beats earnings estimates on US banking strength
Bank of Montreal (TSX:BMO) beat analyst estimates in the third quarter, driven by stronger-than-expected results from its US banking and capital markets...
proactiveinvestors.comAug 25, 2026 · 7:48 AM
Generate Biomedicines stock jumps as post-IPO lock-up set to expire
Shares of Generate Biomedicines Inc (NASDAQ:GENB) jumped more than 20% on Tuesday as investors positioned ahead of the expiration of the company's post-IPO...
proactiveinvestors.comAug 25, 2026 · 7:10 AM
Nasdaq rises as Wall Street gets relief from falling yields
11:00am: Consumer confidence falls US consumer confidence and new home sales both came in below expectations in August, adding to signs of caution among...
proactiveinvestors.comAug 25, 2026 · 7:05 AM
Dick's Sporting Goods stock craters on earnings miss
Dick's Sporting Goods (NYSE:DKS) shares plunged more than 27% on Tuesday after the retailer's second-quarter results missed profit estimates, as weakness at...
proactiveinvestors.comAug 25, 2026 · 6:46 AM
Fiserv cuts 2026 outlook as Q2 earnings, revenue miss estimates
Fiserv Inc (NYSE:FI) shares fell more than 3% on Thursday after the payments and financial technology company lowered its 2026 outlook, while second quarter...
proactiveinvestors.comAug 6, 2026 · 8:32 AM
US drug agency to fund further testing of Solvonis addiction candidate - UPDATE
Shares in Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) rose 7% to 0.15p after it cleared the first hurdle in a US government testing programme for an...
proactiveinvestors.comAug 6, 2026 · 7:23 AM
US Research house initiates Solvonis coverage citing differentiated addiction strategy
Water Tower Research has initiated coverage of Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF), the London-listed biopharmaceutical company developing...
proactiveinvestors.comJul 13, 2026 · 6:10 AM
IXICO guidance unchanged after Huntington's cancellations
IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a neuroscience imaging and biomarker analytics company, has confirmed its revenue guidance remains unchanged after...
proactiveinvestors.comJul 13, 2026 · 3:37 AM

SEC Filings

No recent filings indexed.

Frequently Asked Questions About SVNS.L

Where can I find news about SVNS.L?: The latest headlines, third-party analysis, and SEC filings for Solvonis Therapeutics plc (SVNS.L) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are SVNS.L's SEC filings?: Solvonis Therapeutics plc (SVNS.L)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are SVNS.L's earnings call transcripts?: Full earnings call transcripts for Solvonis Therapeutics plc (SVNS.L) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

Solvonis Therapeutics plc

Frequently Asked Questions About SVNS.L

Solvonis Therapeutics plc

Bank of Montreal beats earnings estimates on US banking strength

Generate Biomedicines stock jumps as post-IPO lock-up set to expire

Nasdaq rises as Wall Street gets relief from falling yields

Dick's Sporting Goods stock craters on earnings miss

Fiserv cuts 2026 outlook as Q2 earnings, revenue miss estimates

US drug agency to fund further testing of Solvonis addiction candidate - UPDATE

US Research house initiates Solvonis coverage citing differentiated addiction strategy

IXICO guidance unchanged after Huntington's cancellations

Frequently Asked Questions About SVNS.L

Bank of Montreal beats earnings estimates on US banking strength

Generate Biomedicines stock jumps as post-IPO lock-up set to expire

Nasdaq rises as Wall Street gets relief from falling yields

Dick's Sporting Goods stock craters on earnings miss

Fiserv cuts 2026 outlook as Q2 earnings, revenue miss estimates

US drug agency to fund further testing of Solvonis addiction candidate - UPDATE

US Research house initiates Solvonis coverage citing differentiated addiction strategy

IXICO guidance unchanged after Huntington's cancellations